首页> 外文期刊>Proteomics >Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis
【24h】

Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis

机译:iTRAQ耦合二维LC-MS / MS分析乙型肝炎病毒复制大鼠原代肝细胞和HepG2细胞中的蛋白谱:对肝脏血管生成的见解

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hepatitis B virus (HBV) infection and in particular Hepatitis B Virus X Protein have been shown to modulate angiogenesis. However, a comprehensive and coordinated mechanism in the HBV-induced angiogenesis remains to be established. In this study, transient transfection of replicative HBV genome was carried out in rat primary hepatocytes (RPHs) as well as HepG2 cells. Angiogenesis was assessed by tube formation assay. 2-D LC-MS/MS analysis was used to detect differentially expressed proteins in cells, supporting HBV replication compared with those transfected with the empty vector. A cell-based HBV replication was established in both RPHs and HepG2 cells. HBV replication-induced angiogenesis was indicated by tube formation of endothelial cells cultured in condition medium from RPHs or HepG2 cells supporting HBV replication. Enzymes associated with angiogenesis, namely fumarate hydratase and tryptophanyl-tRNA synthetase, were identified by 2-D LC-MS/MS analysis in HBV replicating RPHs and HepG2 cells. Our results indicated that the application of quantitative proteomics based on iTRAQ can be an effective approach to evaluate the effects of HBV replication on liver angiogenesis. The angiogenesis-associated proteins identified in our study may eventually lead to novel anti-angiogenic hepatocellular carcinoma cancer therapy based on tumor vascular targeting or be the markers for hepatocellular carcinoma diagnosis.
机译:乙型肝炎病毒(HBV)感染,尤其是乙型肝炎病毒X蛋白已显示出调节血管生成的作用。然而,在HBV诱导的血管生成中全面而协调的机制仍有待建立。在这项研究中,复制性HBV基因组的瞬时转染是在大鼠原代肝细胞(RPH)和HepG2细胞中进行的。通过管形成试验评估血管生成。使用2-D LC-MS / MS分析检测细胞中差异表达的蛋白质,与用空载体转染的蛋白质相比,支持HBV复制。在RPH和HepG2细胞中都建立了基于细胞的HBV复制。 HBV复制诱导的血管生成通过在条件培养基中从支持HBV复制的RPH或HepG2细胞中培养的内皮细胞的管形成来表明。通过2-D LC-MS / MS分析,在复制HBV的RPH和HepG2细胞中鉴定了与血管生成相关的酶,即富马酸盐水合酶和色氨酸-tRNA合成酶。我们的结果表明,基于iTRAQ的定量蛋白质组学的应用可能是评估HBV复制对肝血管生成的影响的有效方法。在我们的研究中鉴定出的与血管生成相关的蛋白质最终可能会导致基于肿瘤血管靶向的新型抗血管生成性肝细胞癌治疗或成为肝细胞癌诊断的标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号